Evaluating Biologic Therapies for Psoriasis: Strategies to Reduce Cost and Improve Patient Access and Outcomes

Evaluating Biologic Therapies for Psoriasis: Strategies to Reduce Cost and Improve Patient Access and Outcomes is organized by North American Center for Continuing Medical Education (NACCME) and would be held during Jul 8, 2016 - Jul, 8, 2017.

The target audience for this medical event are pharmacy directors, medical directors, and other decision makers working in managed care organizations. This CME conference has been approved with a maximum of 1 AMA PRA Category 1 Credit.

Learning Objectives
After completing this activity, participants should be able to:
• Quantify the clinical and economic consequences of suboptimal screening, delayed treatment, and patient nonadherence within the management of psoriasis and associated comorbidities
• Distinguish between the efficacy, safety, and pharmacoeconomic profiles of biologic therapies
• Translate consensus statements and recent clinical outcomes data of biologic therapies to informed formulary decisions
• Employ health plan strategies that assist providers in improving screening, monitoring, and patient adherence to treatment